JP2018509478A5 - - Google Patents

Download PDF

Info

Publication number
JP2018509478A5
JP2018509478A5 JP2018502049A JP2018502049A JP2018509478A5 JP 2018509478 A5 JP2018509478 A5 JP 2018509478A5 JP 2018502049 A JP2018502049 A JP 2018502049A JP 2018502049 A JP2018502049 A JP 2018502049A JP 2018509478 A5 JP2018509478 A5 JP 2018509478A5
Authority
JP
Japan
Prior art keywords
composition
potato polysaccharide
polysaccharide preparation
potato
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018502049A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018509478A (ja
JP6793180B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/024283 external-priority patent/WO2016160590A1/en
Publication of JP2018509478A publication Critical patent/JP2018509478A/ja
Publication of JP2018509478A5 publication Critical patent/JP2018509478A5/ja
Application granted granted Critical
Publication of JP6793180B2 publication Critical patent/JP6793180B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018502049A 2015-03-27 2016-03-25 癌を治療するための方法および物質 Expired - Fee Related JP6793180B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562139163P 2015-03-27 2015-03-27
US62/139,163 2015-03-27
PCT/US2016/024283 WO2016160590A1 (en) 2015-03-27 2016-03-25 Methods and materials for treating cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020186326A Division JP2021038235A (ja) 2015-03-27 2020-11-09 癌を治療するための方法および物質

Publications (3)

Publication Number Publication Date
JP2018509478A JP2018509478A (ja) 2018-04-05
JP2018509478A5 true JP2018509478A5 (https=) 2019-04-25
JP6793180B2 JP6793180B2 (ja) 2020-12-02

Family

ID=57007473

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018502049A Expired - Fee Related JP6793180B2 (ja) 2015-03-27 2016-03-25 癌を治療するための方法および物質
JP2020186326A Pending JP2021038235A (ja) 2015-03-27 2020-11-09 癌を治療するための方法および物質

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020186326A Pending JP2021038235A (ja) 2015-03-27 2020-11-09 癌を治療するための方法および物質

Country Status (6)

Country Link
US (1) US20180078599A1 (https=)
EP (1) EP3273970B1 (https=)
JP (2) JP6793180B2 (https=)
AU (2) AU2016243512A1 (https=)
CA (1) CA2981135C (https=)
WO (1) WO2016160590A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014321711B2 (en) 2013-09-19 2019-11-14 The Research Foundation For The State University Of New York Methods and materials for treating diabetes or liver steatosis
WO2016160594A1 (en) 2015-03-27 2016-10-06 The Research Foundation For The State University Of New York Methods and materials for reducing amyloid beta levels within a mammal
CN110575450B (zh) * 2019-09-17 2023-03-31 遵义医科大学珠海校区 2,5-呋喃二甲醇在制备抗肿瘤药物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050053664A1 (en) * 2003-09-08 2005-03-10 Eliezer Zomer Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
WO2012016050A2 (en) * 2010-07-28 2012-02-02 The General Hospital Corporation Chemoradiotherapy for kras-mutant colorectal cancer
EP2773345A1 (en) * 2011-11-02 2014-09-10 Synta Pharmaceuticals Corp. Cancer therapy using a combination of hsp90 inhibitors with topoisomerase i inhibitors
CA2868921C (en) * 2012-03-28 2022-03-01 The Research Foundation For The State University Of New York Methods and materials related to nutritional supplement compositions containing a potato polysaccharide preparation
WO2014051076A1 (ja) * 2012-09-28 2014-04-03 株式会社Ｂｎａ Ｂｎａクランプ法
US20170035917A1 (en) * 2013-06-10 2017-02-09 Millennium Pharmaceuticals, Inc. Methods of treatment of cancer
AU2014321711B2 (en) * 2013-09-19 2019-11-14 The Research Foundation For The State University Of New York Methods and materials for treating diabetes or liver steatosis

Similar Documents

Publication Publication Date Title
Dolan et al. The prognostic value of the systemic inflammatory response in randomised clinical trials in cancer: a systematic review
Oronsky et al. What's new in SCLC? A review
JP2021169479A5 (https=)
Gill et al. New targets and approaches in osteosarcoma
Higuchi et al. Biweekly irinotecan plus cisplatin versus irinotecan alone as second-line treatment for advanced gastric cancer: a randomised phase III trial (TCOG GI-0801/BIRIP trial)
Kasper et al. Targeted therapies in gastroesophageal cancer
Herreros-Villanueva et al. Adjuvant and neoadjuvant treatment in pancreatic cancer
Lignon et al. Rituximab, dexamethasone, cytarabine, and oxaliplatin (R-DHAX) is an effective and safe salvage regimen in relapsed/refractory B-cell non-Hodgkin lymphoma
JP2016204387A5 (https=)
IL312318A (en) Biomarkers for nanoparticle preparations
JP2018509478A5 (https=)
JP2019528288A5 (https=)
HRP20191145T1 (hr) Postupak predviđanja ishoda liječenja s afliberceptom kod pacijenta za kojeg se sumnja da ima rak
Suzuki et al. In vitro and in vivo anti-tumor effects of brexpiprazole, a newly-developed serotonin-dopamine activity modulator with an improved safety profile
Trivedi et al. A phase I trial of the mTOR inhibitor temsirolimus in combination with capecitabine in patients with advanced malignancies
Roviello et al. Maintenance in gastric cancer: New life for an old issue?
Lauriola et al. Targeting the interplay of independent cellular pathways and immunity: A challenge in cancer immunotherapy
JP2021509679A5 (https=)
Takashima et al. Standard first-line chemotherapy for metastatic gastric cancer in Japan has met the global standard: evidence from recent phase III trials
Romanidou et al. Therapies in the pipeline for small-cell lung cancer.
Wu et al. A predictive model for evaluating responsiveness to pemetrexed treatment in patients with advanced colorectal cancer
JP6174044B2 (ja) Ｅｇｆｒ阻害剤と組み合わせたテトラヒドロフォレート
Yin et al. Sodium citrate pretreatment enhances CAR-T cell persistence and anti-tumor efficacy through inhibition of calcium signaling
RU2015119802A (ru) Комбинированная терапия рака
JPWO2020257536A5 (https=)